Future work will focus on implementing this approach in established cancer-on-a-chip models to correlate IL-8 secretion dynamics with treatment response, thereby enhancing the predictive power of these in vitro platforms for drug screening and personalized medicine applications. This evidence concerns the gene CXCL8 and cancer.